Recruiting

Imaging Methods

Sponsor:

Mayo Clinic

Code:

NCT06470711

Conditions

Malignant Glioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Non-Interventional Study

Study Details

Brief summary:

This study evaluates imaging methods for monitoring neural and electrical activity in the brain for improving clinical diagnosis.

Conditions

Malignant Glioma

Study ID

NCT06470711

Start date

Sep 13, 2024

Status verified date

Jan, 2026

Completion date

Sep 30, 2027

Anticipated

Primary completion date

Sep 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Aim 1: normal healthy volunteers
  • Aim 2, 3, 4: participants included in IRB 16-002424, including those that have undergone surgical biopsy/resection for suspected or known glioma

Exclusion Criteria:

  • Healthy volunteer unable to have an MRI

Study Design

Enrollment

120 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational

Participants complete a survey and undergo MRI on study.

Interventions

Non-Interventional Study

Non-interventional study

Primary outcome measure

  • Identify diffusion MRI metrics [using conductivity tensor imaging (CTI)] that inform of regional electrical properties in the brain [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Locations

Mayo Clinic in Arizona

Recruiting

Scottsdale, Arizona, United States, 85259

Contacts

Clinical Trials Referral Office

855-776-0015mayocliniccancerstudies@mayo.edu

Principal Investigator:

Leland S. Hu, MD

More Information

Sponsor

Mayo Clinic

Last update posted

Feb 3, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-02-03.